Adaptive clinical trial design with delayed treatment effects using elicited prior distributions

James Salsbury, Jeremy Oakley, Steven Julious +1

Clinical trials with time-to-event endpoints, such as overall survival (OS) or progression-free survival (PFS), are fundamental for evaluating new treatments, particularly in immun…